K. R. Eminova

K. R. Eminova

Auto-generated profile, based on publicly available information

K. R. Eminova

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2024 in Pirogov Russian Journal of Surgery
Verified
Journal Article
Closed access
ZBZelimkhan G. Berikkhanov
Zelimkhan G. Berikkhanov
SASergey Avdeev
Sergey Avdeev
GNGalina Nekludova
Galina Nekludova
ETEvgeny A. Tarabrin
Evgeny A. Tarabrin
KEK.R. Eminova
K.R. Eminova
NKN.N. Khlistunova
N.N. Khlistunova
Objective. To identify the risk factors of pulmonary cavitation in COVID-19 pneumonia. Material and methods. A retrospective study included 8261 patients with COVID-19 between April 2020 and March 2022. Inclusion criteria: age >18 years, COVID-19 confirmed by polymerase chain reaction. Two cohorts of patients were formed: 40 patients with pulmonary cavitation and 40 patients without these lesions. Both groups were comparable in age, lung lesion volume and oxygenation. Sex, age, length of hospital-stay, CT grade of lung lesion, comorbidities, treatment, respiratory support, oxygen saturation and in-hospital outcomes were evaluated. The highest lung lesion volume during hospitalization was assessed. CT was performed upon admission and approximately every 5 days for evaluation of treatment. Statistical analysis was performed using the IBM SPSS Statistics software (IBM Corporation, USA). Results. Patients with pulmonary cavitation significantly differed in age, SpO2, lung lesion volume, more common non-invasive ventilation and prolonged hospital-stay. Cardiovascular diseases were more common in both groups. Univariate logistic regression analysis revealed age, cardiovascular diseases, CT-based severity of lung damage, absence of biological therapy and non-invasive ventilation as risk factors of pulmonary cavitation. According to multivariate logistic regression analysis, these predictors were CT-based severity of lung damage and absence of biological therapy. Univariate logistic regression analysis showed that pulmonary cavitation had no significant effect on mortality (OR=2.613, 95% CI: 0.732—9.322, p=0.139). Conclusion. The risk of pulmonary cavitation in COVID-19 is directly related to advanced lung damage and untimely or absent biological therapy with IL-6 inhibitors. Pulmonary cavitation in COVID-19 is not a typical manifestation of disease and can be caused by some factors: fungal infection, secondary bacterial infection, tuberculosis and pulmonary infarction. Further study of this problem is required to develop diagnostic algorithms and treatment tactics.

13 January 2026 in Siberian journal of oncology
Verified
Journal Article
Open access
PDF file
TBT. S. Berestok
T. S. Berestok
MEM. S. Ermoshchenkova
M. S. Ermoshchenkova
VGV. N. Galkin
V. N. Galkin
ASA. B. Semenova
A. B. Semenova
VDV. V. Didenko
V. V. Didenko
KEK. R. Eminova
K. R. Eminova
Background. Adenomyoepithelioma of the breast is a rare benign tumor characterized by biphasic proliferation of epithelial and myoepithelial cells of the lobular and ductal components of the breast. Although benign, adenomyoepithelioma has a potential for malignant transformation; therefore its early detection is crucial. Currently, there are no established clinical, radiological and morphological criteria for early detection of this type of tumor, which can complicate diagnosis and requires histological examination of the tumor. Description of the clinical case. A 39-year-old female patient presented to the Oncology Center No. 1 of the S.S. Yudin Clinical Hospital with the breast neoplasm detected during a routine examination. Ultrasound examination showed fibroadenoma. Histological examination of the trepan biopsy specimen revealed adenomyoepithelioma. The patient underwent a sectoral resection of the right breast. Histology and immunohistochemistry confirmed the diagnosis of adenomyoepithelioma. Conclusion . Breast adenomyoepithelioma is a rare tumor diagnosed by histology/immunohistochemistry, with surgery as a main treatment. Further research is needed to study the pathogenesis.